{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=DNA+reports&page=2", "query": { "intervention": "DNA reports", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=DNA+reports&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-13T13:42:08.207Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07557303", "title": "Supporting Just-In-Time Consent for Prenatal Screening: The INFORM Study", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Delivery of Health Care", "Genetic Testing", "Humans", "Pregnancy", "Noninvasive Prenatal Testing", "Informed Consent", "Internet-Based Intervention", "Self Efficacy", "Pregnant People", "Decision Making", "Health Education", "Patient Education as Topic/Method" ], "interventions": [ { "name": "Mobile-based Educational Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Case Western Reserve University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 1400, "start_date": "2026-08-01", "completion_date": "2028-06-30", "has_results": false, "last_update_posted_date": "2026-07-23", "last_synced_at": "2026-09-13T13:42:08.207Z", "location_count": 3, "location_summary": "San Francisco, California • Jacksonville, Florida • Chapel Hill, North Carolina", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07557303" }, { "nct_id": "NCT02706639", "title": "Williams Syndrome (WS) and Supravalvar Aortic Stenosis (SVAS) DNA and Tissue Bank", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Williams Syndrome", "Supravalvular Aortic Stenosis", "Cardiovascular Disease" ], "interventions": [], "intervention_types": [], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Day", "maximum_age": "85 Years", "sex": "ALL", "summary": "1 Day to 85 Years" }, "enrollment_count": 305, "start_date": "2016-05-11", "completion_date": "2025-03-07", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-09-13T13:42:08.207Z", "location_count": 3, "location_summary": "Bethesda, Maryland • St Louis, Missouri • Columbus, Ohio", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02706639" }, { "nct_id": "NCT06266689", "title": "Project humAn dieTary daTa rEtuRN", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diet Habit" ], "interventions": [ { "name": "Personalized Diet Information", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": "12 Months", "sex": "ALL", "summary": "Up to 12 Months" }, "enrollment_count": 600, "start_date": "2024-02-27", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-01-29", "last_synced_at": "2026-09-13T13:42:08.207Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06266689" }, { "nct_id": "NCT03970447", "title": "A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Glioblastoma" ], "interventions": [ { "name": "Temozolomide", "type": "DRUG" }, { "name": "Lomustine", "type": "DRUG" }, { "name": "Regorafenib", "type": "DRUG" }, { "name": "Radiation", "type": "RADIATION" }, { "name": "Paxalisib", "type": "DRUG" }, { "name": "VAL-083", "type": "DRUG" }, { "name": "VT1021", "type": "DRUG" }, { "name": "Troriluzole", "type": "DRUG" }, { "name": "ADI-PEG 20", "type": "BIOLOGICAL" }, { "name": "AZD1390", "type": "DRUG" }, { "name": "Tinostamustine", "type": "DRUG" } ], "intervention_types": [ "DRUG", "RADIATION", "BIOLOGICAL" ], "sponsor": "Global Coalition for Adaptive Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2250, "start_date": "2019-07-30", "completion_date": "2030-06", "has_results": false, "last_update_posted_date": "2026-07-30", "last_synced_at": "2026-09-13T13:42:08.207Z", "location_count": 42, "location_summary": "Birmingham, Alabama • La Jolla, California • Los Angeles, California + 31 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03970447" }, { "nct_id": "NCT03259438", "title": "The Vitality Project for Fatigued Female Cancer Survivors", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Fatigue", "Cancer Survivorship" ], "interventions": [ { "name": "Qigong", "type": "BEHAVIORAL" }, { "name": "Healthy Living (CHIP + Pre-Train)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "The Miriam Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "18 Years to 70 Years · Female only" }, "enrollment_count": 75, "start_date": "2017-07-24", "completion_date": "2018-01-30", "has_results": false, "last_update_posted_date": "2017-08-23", "last_synced_at": "2026-09-13T13:42:08.207Z", "location_count": 1, "location_summary": "Providence, Rhode Island", "locations": [ { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT03259438" }, { "nct_id": "NCT00977119", "title": "Investigation of Genetic Determinants of Capecitabine Toxicity", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Side-effect questionnaires", "type": "OTHER" }, { "name": "research blood samples", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 240, "start_date": "2009-11-23", "completion_date": "2021-06-21", "has_results": false, "last_update_posted_date": "2024-07-31", "last_synced_at": "2026-09-13T13:42:08.207Z", "location_count": 13, "location_summary": "Birmingham, Alabama • Washington D.C., District of Columbia • Chicago, Illinois + 9 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Evanston", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00977119" }, { "nct_id": "NCT03372902", "title": "Development Of A Blood Test To Improve The Performance Of Breast Cancer Screening", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer", "Breast Benign" ], "interventions": [ { "name": "Breast MRI", "type": "DEVICE" }, { "name": "Breast Mammogram", "type": "DEVICE" }, { "name": "Blood draw", "type": "OTHER" }, { "name": "Breast Biopsy", "type": "PROCEDURE" }, { "name": "online participant reported questionnaire", "type": "BEHAVIORAL" } ], "intervention_types": [ "DEVICE", "OTHER", "PROCEDURE", "BEHAVIORAL" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 628, "start_date": "2017-12-07", "completion_date": "2025-03-12", "has_results": false, "last_update_posted_date": "2025-03-14", "last_synced_at": "2026-09-13T13:42:08.207Z", "location_count": 7, "location_summary": "Hartford, Connecticut • Miami, Florida • Basking Ridge, New Jersey + 4 more", "locations": [ { "city": "Hartford", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" }, { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Commack", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03372902" }, { "nct_id": "NCT04683731", "title": "Helping Patients and Providers Make Better Decisions About Colorectal Cancer Screening", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer Screening Tests" ], "interventions": [ { "name": "Decision aid without personalized message", "type": "BEHAVIORAL" }, { "name": "Decision aid with personalized message", "type": "BEHAVIORAL" }, { "name": "Provider notification without personalized message", "type": "BEHAVIORAL" }, { "name": "Provider notification with personalized message", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "50 Years to 75 Years" }, "enrollment_count": 1111, "start_date": "2021-01-19", "completion_date": "2023-07-31", "has_results": true, "last_update_posted_date": "2024-12-13", "last_synced_at": "2026-09-13T13:42:08.207Z", "location_count": 2, "location_summary": "Indianapolis, Indiana", "locations": [ { "city": "Indianapolis", "state": "Indiana" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04683731" }, { "nct_id": "NCT03829176", "title": "Investigating the Feasibility and Implementation of Whole Genome Sequencing in Patients With Suspected Genetic Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hereditary Disease", "Genetic Predisposition to Disease" ], "interventions": [ { "name": "Whole Genome Sequencing", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": null, "sex": "ALL", "summary": "3 Months and older" }, "enrollment_count": 200, "start_date": "2018-03-01", "completion_date": "2020-10-01", "has_results": false, "last_update_posted_date": "2020-11-18", "last_synced_at": "2026-09-13T13:42:08.207Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03829176" }, { "nct_id": "NCT07504796", "title": "ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Melanoma", "Advanced Melanoma" ], "interventions": [ { "name": "Nivolumab", "type": "DRUG" }, { "name": "Relatlimab", "type": "DRUG" }, { "name": "Ipilimumab", "type": "DRUG" }, { "name": "Signatera genome MRD assay", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 90, "start_date": "2026-04-13", "completion_date": "2031-05", "has_results": false, "last_update_posted_date": "2026-08-24", "last_synced_at": "2026-09-13T13:42:08.207Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07504796" } ] }